1.Effects of misgurnus anguillicaudatus polysaccharides on antihypoxia capacity in mice
Jun ZHOU ; Chenxiao ZHANG ; Kaixun HUANG ;
Chinese Pharmacological Bulletin 2003;0(10):-
AIM The effects of misgurnus anguillicaudatus Polysaccharides(MAP) on the antihypoxia capacity in mice were studied. METHODS The mice were administered with various doses of MAP for 14 days and then were exposed to hypoxia. The survival time in mice, the content of hemoglobin (Hb), the content of MDA and the activity of superoxide dismutase (SOD) were examined. RESULTS MAP significantly prolonged the survival time in mice exposed to hypoxia. The optimal dose was 50 mg?kg -1 ?d -1 . MAP could inhibit lipid peroxidation in tissues, and increase Hb content and the activity of SOD in plasma. CONCLUSION MAP are the biological active components in Misgurnus anguillicaudatus against hypoxia.
2.The study of histone H3 lysine 4 trimethylation in peripheral blood mononuclear cells of systemic lupus erythematosus patients
Li ZHANG ; Yong DAI ; Chenxiao HU ; Yanliang ZHANG
Chinese Journal of Rheumatology 2009;13(2):98-102
Objective To study histone H3 lysine 4 trimethylation (H3K4me3) in peripheral blood mononuclear cells (PBMCs) of systemic lupus erythematosus(SLE) patients.Methods PBMCs were isolated by density gradient centrifugation from 10 active SLE patients,7 inactive SLE patients and 8 healthy volunteers.Chromatin immunopreeipitation linked to mieroarrays (ChIP-chip) was used to profile the variations in H3K4me3 in CpG island regions in PBMCs of SLE patients and controls.ChIP-qPCR was used to validate the mieroarray results.To confirm correlations between H3K4me3 and gene expression,expression analysis by qRT-PCR was performed on three randomly selected H3K4me3 candidates.Results 413 (137 increased and 276 decreased H3K4me3) and 393 genes (112 increased and 281 decreased H3K4me3) displayed significant differences in H3K4me3 between active and inactive SLE when compared with healthy SUhjeets.The results of ChiP-qPCR were consistent with microarray.ConclusiOn There are significant differences in H3K4me3 profiling between SLE and healthy subjects.These novel candidate genes may be potential biomarkers for future therapeutic targets.The ChIP-chip technology can help further reveal SLE molecular mechanisms and discover new therapeutic targets.
3.High-dose methotrexate and L-asparaginase for the treatment of adult patients with high risk Ph-acute lymphoblastic leukemia
Yue ZHANG ; Hui ZENG ; Juan ZHANG ; Chenxiao FU ; Hebing ZHOU
Journal of Leukemia & Lymphoma 2015;24(12):740-742,745
Objective To explore the efficacy and safety of high-dose methotrexate (MTX) and L-asparaginase (L-Asp) for the treatment of adult patients with high risk Ph acute lymphoblastic leukemia (ALL).Methods Five adult patients with high risk Ph-ALL were treated with several courses of MTX (3-5 g/m2 by continually intravenous drip for 24 h) and L-Asp (8 000-10 000 U/time, once a day, 10 times for one cycle).Results Five patients were disease-free survival, their survival time was 60-96 months and the median survival time was 73 months.The chemotherapy-related bone marrow depression was mild.No obvious liver and kidney damage, severe allergic reaction and pancreatitis were observed.Conclusion Highdose MTX and L-Asp are effective and well tolerated, and may contribute to long-term survival of adult patients with high risk Ph-ALL.
4.Augmented reality navigation system for assisting CT-guided puncture of pulmonary nodules in dog models
Tao ZHOU ; Nannan SUN ; Xiaobo FAN ; Xiu WANG ; Zhengyi XIE ; Yuqing SUN ; Chenxiao YANG ; Chunming XU ; Shouyu ZHANG ; Zhuangfei MA ; Min ZHANG ; Shouqiang JIA
Chinese Journal of Interventional Imaging and Therapy 2024;21(1):38-41
Objective To observe the value of augmented reality(AR)navigation system for assisting CT-guided puncture of pulmonary nodules in dog models.Methods Five healthy dogs were selected,and 4 target lung rings were implanted in each dog to build pulmonary nodule models.Deferring to crossover design,CT-guided punctures were performed with or without AR navigation 2 and 4 weeks after successful modeling,respectively,while punctures with AR navigation were regarded as AR group and the others as conventional group,respectively.The time duration of puncturing,the times of CT scanning,of needle adjustment,and the deviation distance between needle pinpoint to the center of pulmonary nodule shown on three-dimensional reconstruction were compared between groups.Results The duration time of puncture in AR group and conventional group was(13.62±5.11)min and(20.16±4.76)min,respectively.In AR group,the times of CT scanning,of needle adjustment,and the deviation distance was 2.40±0.50,2.75±0.44 and(2.94±1.92)mm,respectively,while in conventional group was 3.10±0.64,3.70±0.57 and(4.90±3.38)mm,respectively.The introduction of AR navigation was helpful to shortening the duration of puncture,reducing times of CT scanning and needle adjustment,also decreasing positioning error of needle pinpoint(all P<0.05).In contrast,the variance of puncture sequences and dogs had no obvious effect on the results(both P>0.05).Conclusion AR navigation system could improve accuracy and efficiency in CT-guided puncture of pulmonary nodules in dog models.
5.Pathogenesis, diagnosis, and treatment of pancreatogenic diabetes
Xiwang WANG ; Jingjing JIN ; Ying WANG ; Chenxiao WANG ; Yonghua ZHANG ; Yajiao GU ; Xiao WANG
Journal of Clinical Hepatology 2024;40(5):1068-1072
Pancreatogenic diabetes is a type of diabetes mellitus secondary to exocrine pancreatic disease, and it was officially proposed by the American Diabetes Association in 2014, with chronic pancreatitis as the most common etiology, followed by pancreatic cancer. At present, the misdiagnosis rate of this disease is extremely high, and patients with pancreatogenic diabetes have a higher risk of death and readmission than patients with type 2 diabetes. Therefore, it is of great significance to fully understand, correctly identify, and diagnose pancreatogenic diabetes in the early state, so as to reduce the disability rate and mortality rate of this disease. This article reviews the advances in the possible pathogenesis, diagnosis, treatment, and management of pancreatic diabetes secondary to pancreatitis and pancreatic cancer.